New products
BCAL Diagnostics develops blood test to evaluate breast cancer
BCAL Diagnostics is developing BREASTEST Monitor, a blood test designed to help evaluate women for local breast cancer recurrence following treatment. The test aims to provide a non-invasive monitoring option for post-treatment breast cancer patients.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network